151 related articles for article (PubMed ID: 11469799)
1. Proteolytic processing of the human T-cell lymphotropic virus 1 reverse transcriptase: identification of the N-terminal cleavage site by mass spectrometry.
Agbuya PG; Sherman NE; Moen LK
Arch Biochem Biophys; 2001 Aug; 392(1):93-102. PubMed ID: 11469799
[TBL] [Abstract][Full Text] [Related]
2. Identification of the RT-RH/IN cleavage site of HTLV-I.
Mariani VL; Shuker SB
Biochem Biophys Res Commun; 2003 Jan; 300(2):268-70. PubMed ID: 12504078
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic cleavage at the Gag-Pol junction in avian leukosis virus: differences in vitro and in vivo.
Stewart L; Vogt VM
Virology; 1994 Oct; 204(1):45-59. PubMed ID: 7522375
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of the N-terminal domain of the human T-cell leukemia virus capsid protein.
Cornilescu CC; Bouamr F; Yao X; Carter C; Tjandra N
J Mol Biol; 2001 Mar; 306(4):783-97. PubMed ID: 11243788
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
Paulus C; Ludwig C; Wagner R
Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852
[TBL] [Abstract][Full Text] [Related]
7. Identification of HTLV-I gag protease and its sequential processing of the gag gene product.
Hatanaka M; Nam SH
J Cell Biochem; 1989 May; 40(1):15-30. PubMed ID: 2663887
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of human T cell leukemia virus type 1 to reverse-transcriptase inhibitors: evidence for resistance to lamivudine.
García-Lerma JG; Nidtha S; Heneine W
J Infect Dis; 2001 Aug; 184(4):507-10. PubMed ID: 11471110
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase.
Fan N; Rank KB; Poppe SM; Tarpley WG; Sharma SK
Biochemistry; 1996 Feb; 35(6):1911-7. PubMed ID: 8639674
[TBL] [Abstract][Full Text] [Related]
10. A novel protease processing site in the transframe protein of human T-cell leukemia virus type 1 PR76(gag-pro) defines the N terminus of RT.
Heidecker G; Hill S; Lloyd PA; Derse D
J Virol; 2002 Dec; 76(24):13101-5. PubMed ID: 12438640
[TBL] [Abstract][Full Text] [Related]
11. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
[TBL] [Abstract][Full Text] [Related]
12. Kinetic characterization of newly discovered inhibitors of various constructs of human T-cell leukemia virus-1 (HTLV-1) protease and their effect on HTLV-1-infected cells.
Demir A; Oguariri RM; Magis A; Ostrov DA; Imamichi T; Dunn BM
Antivir Ther; 2012; 17(5):883-92. PubMed ID: 22436331
[TBL] [Abstract][Full Text] [Related]
13. Zidovudine treatment is not associated with HTLV-1 reverse transcriptase gene mutations in HTLV-I/HIV-1 co-infected patients.
Gasmi M; Fillon S; Leriche K; Neisson-Vernant C; Desgranges C
Antivir Ther; 1997 Apr; 2(2):91-7. PubMed ID: 11322280
[TBL] [Abstract][Full Text] [Related]
14. Analysis of human lymphotropic T-cell virus type II-like particle production by recombinant baculovirus-infected insect cells.
Takahashi RH; Nagashima K; Kurata T; Takahashi H
Virology; 1999 Apr; 256(2):371-80. PubMed ID: 10191202
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic processing of human lactase-phlorizin hydrolase is a two-step event: identification of the cleavage sites.
Wüthrich M; Grünberg J; Hahn D; Jacob R; Radebach I; Naim HY; Sterchi EE
Arch Biochem Biophys; 1996 Dec; 336(1):27-34. PubMed ID: 8951031
[TBL] [Abstract][Full Text] [Related]
16. Human T-cell leukemia virus type 1 reverse transcriptase (RT) originates from the pro and pol open reading frames and requires the presence of RT-RNase H (RH) and RT-RH-integrase proteins for its activity.
Trentin B; Rebeyrotte N; Mamoun RZ
J Virol; 1998 Aug; 72(8):6504-10. PubMed ID: 9658093
[TBL] [Abstract][Full Text] [Related]
17. Domain organization and DNA-induced conformational changes of an archaeal family B DNA polymerase.
Pisani FM; Manco G; Carratore V; Rossi M
Biochemistry; 1996 Jul; 35(28):9158-66. PubMed ID: 8703921
[TBL] [Abstract][Full Text] [Related]
18. Substrates and inhibitors of human T-cell leukemia virus type I protease.
Ding YS; Rich DH; Ikeda RA
Biochemistry; 1998 Dec; 37(50):17514-8. PubMed ID: 9860866
[TBL] [Abstract][Full Text] [Related]
19. Production of "authentic" poliovirus RNA-dependent RNA polymerase (3D(pol)) by ubiquitin-protease-mediated cleavage in Escherichia coli.
Gohara DW; Ha CS; Kumar S; Ghosh B; Arnold JJ; Wisniewski TJ; Cameron CE
Protein Expr Purif; 1999 Oct; 17(1):128-38. PubMed ID: 10497078
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of alpha-lytic protease by pro region C-terminal steric occlusion of the active site.
Sohl JL; Shiau AK; Rader SD; Wilk BJ; Agard DA
Biochemistry; 1997 Apr; 36(13):3894-902. PubMed ID: 9092819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
